changing your setting. We'll assume that you are happy to receive all cookies on the BTG website.
LC Bead LUMI™ press releases and related news and business articles.
19 Aug 2019
Boston Scientific Corporation (NYSE: BSX) today announced the completion of its acquisition of BTG plc. (LSE:BTG) pursuant to the previously announced scheme of arrangement. BTG develops and commercializes products used in minimally-invasive procedures targeting cancer and vascular diseases, as well as specialty pharmaceuticals.
7 Sep 2018
BTG plc (LSE: BTG), the global specialist healthcare company, today announces it has acquired Novate Medical Ltd. (“Novate”), a medical device company focused on the prevention of pulmonary embolism (PE) in patients at high risk of venous thromboembolic events.
5 Oct 2017
London, UK, 5 October 2017: BTG plc (LSE: BTG), the global specialist healthcare company, today announces it has acquired Roxwood Medical (“Roxwood”), an innovative provider of advanced cardiovascular specialty catheters used in the treatment of patients with severe coronary and peripheral artery disease.
15 Feb 2017
BTG plc (LSE: BTG), the global specialist healthcare company, today announced a collaboration with the Society of Interventional Oncology (SIO), a global organization working to nurture and support interventional oncology worldwide, to explore the role of interventional oncology alongside immuno-oncology
1 Apr 2016
First and only, commercially available, radiopaque embolic bead in the US has potential to revolutionize treatment of hypervascular tumors and arteriovenous malformations
3 Feb 2016
Collaboration brings new tools to interventional radiologists and oncologists to
help treat liver cancer and enhanced patient care
14 Dec 2015
Unique LC Bead LUMI™ provides real-time visible confirmation of bead location during embolisation of hypervascular tumours and arteriovenous malformations
Select CONTINUE to proceed to the BTG website or LEAVE to learn more at BSC.com